Pfizer

Sr. Computational Biologist, Tumor Cell Biology

Posted on: 19 Jan 2021

La Jolla, CA

Job Description

Role Summary

We are looking for a talented and highly motivated computational biologist to join a team supporting discovery and development of new therapies targeting tumor intrinsic mechanisms with a focus on Cell Cycle and Epigenetics. The scientist will work in an inter-disciplinary environment and have the opportunity to advance discovery and development of cutting-edge cancer therapeutics. The scientist will closely collaborate with bench biologists to elucidate molecular mechanisms of novel cancer therapies and identify patients most likely to benefit from new and existing therapies. In collaboration with translational oncology leads, the scientist will analyze and interpret data from early clinical development of cancer drugs.

This role also provides an exciting opportunity to work with late stage clinical data to discover new hypothesis for mechanisms of resistance and work with experimentalists to test these hypotheses in preclinical models. The scientist is expected to contribute to the development of novel methods for integrative analysis and biological interpretation of high-dimensional molecular data. The successful candidate should have a strong biological and computational background with proven capability of solving complex problems by creating innovative analytical solutions.

Role Responsibilities

* Collaborate with bench scientists to design and execute computational analysis of large-scale molecular data from preclinical research.
* Collaborate with translational oncologists on analysis of early stage clinical trials molecular data.
* Conduct in silico analysis to help address questions such as predictive biomarker, tumor indication, drug combination and resistance mechanisms.
* Process, analyze and interpret high dimensional data from diverse OMICS platforms.
* Contribute to the development of data packages supporting decision making.
* Actively participate in project teams with multidisciplinary backgrounds to formulate data-driven, actionable hypotheses.
* Devise and leverage state of the art computational approaches for oncology target identification and precision medicine.
* Contribute effectively to a shared codebase that can be leveraged broadly for multiple applications.

Basic Qualifications

* PhD or equivalent in computational biology, genomics or a related field.
* Strong background in integrative cancer biology analysis and biostatistics/machine learning methods.
* Deep knowledge of high throughput molecular profiling and experience in mining big OMICS data.
* Track record of innovative and proactive problem solving, preferably in cancer biology and medicine.
* Proficiency in scientific programming languages (R, Python) in UNIX/LINUX environment and algorithm development.
* Ability to multi-task, effectively communicate (oral and written) and work with diverse expertise teams.

Preferred Qualifications

* Postdoctoral research experience in Cancer Biology
* Experience in productive collaboration with bench and/or translational scientists is highly desirable.
* Experience analyzing single cell sequencing data is a plus.

Other Job Details

* Eligible for Relocation Package
* Eligible for Employee Referral Bonus
* LI-PFE

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Research and Development

LI-PFE

Pfizer

New York, New York

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.

Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.